Regeneron, an expensive monoclonal antibody cocktail, has been approved by the World Health Organization for COVID-19 patients at high risk of hospitalization. Jamie Mauracher explains how the treatment works, why it’s rarely used in Canada, and how some COVID-19 survivors are reacting to the news.
